Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteinase Inhibitory Proteins, Secretory | 22 | 2023 | 48 | 2.640 |
Why?
|
Serine Endopeptidases | 19 | 2023 | 1022 | 1.830 |
Why?
|
Transcription Factor RelA | 4 | 2022 | 254 | 1.210 |
Why?
|
Receptor, PAR-2 | 3 | 2020 | 33 | 0.960 |
Why?
|
Adrenomedullin | 2 | 2023 | 85 | 0.920 |
Why?
|
Supratentorial Neoplasms | 2 | 2022 | 159 | 0.840 |
Why?
|
Glioblastoma | 10 | 2018 | 3482 | 0.800 |
Why?
|
Ependymoma | 2 | 2022 | 320 | 0.730 |
Why?
|
Mouth Neoplasms | 3 | 2021 | 596 | 0.680 |
Why?
|
Membrane Glycoproteins | 10 | 2023 | 3702 | 0.660 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2020 | 181 | 0.650 |
Why?
|
Brain Neoplasms | 11 | 2022 | 9031 | 0.590 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 2 | 2007 | 68 | 0.580 |
Why?
|
Gene Fusion | 1 | 2020 | 356 | 0.580 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 312 | 0.570 |
Why?
|
Genes, Tumor Suppressor | 1 | 2021 | 1062 | 0.550 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2023 | 571 | 0.530 |
Why?
|
Cytoplasm | 1 | 2019 | 1510 | 0.490 |
Why?
|
Colitis | 3 | 2023 | 1233 | 0.480 |
Why?
|
DNA Repair | 2 | 2021 | 2045 | 0.450 |
Why?
|
Hepatocyte Growth Factor | 7 | 2023 | 270 | 0.450 |
Why?
|
Neoplasm Invasiveness | 8 | 2021 | 3595 | 0.440 |
Why?
|
Cyclohexanones | 2 | 2016 | 30 | 0.420 |
Why?
|
Hematopoietic Stem Cells | 5 | 2022 | 3396 | 0.410 |
Why?
|
NF-kappa B | 4 | 2022 | 2490 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2022 | 4026 | 0.400 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2023 | 359 | 0.340 |
Why?
|
Gene Expression | 3 | 2021 | 7581 | 0.330 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2009 | 83 | 0.330 |
Why?
|
Epithelium | 3 | 2023 | 1603 | 0.330 |
Why?
|
Wound Healing | 3 | 2018 | 2805 | 0.320 |
Why?
|
Leukemia, Myeloid | 3 | 2022 | 694 | 0.320 |
Why?
|
Macrophage Migration-Inhibitory Factors | 2 | 2005 | 109 | 0.300 |
Why?
|
Mice | 38 | 2023 | 81525 | 0.290 |
Why?
|
Cell Line, Tumor | 17 | 2021 | 16981 | 0.290 |
Why?
|
Benzamides | 2 | 2016 | 1370 | 0.280 |
Why?
|
Dacarbazine | 1 | 2009 | 559 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2017 | 1727 | 0.270 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 954 | 0.270 |
Why?
|
Calcium | 1 | 2019 | 5722 | 0.270 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2022 | 686 | 0.260 |
Why?
|
Nutritional Status | 1 | 2014 | 1615 | 0.260 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2491 | 0.260 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 617 | 0.260 |
Why?
|
Cell Proliferation | 11 | 2021 | 10445 | 0.250 |
Why?
|
Epithelial Cells | 6 | 2020 | 3673 | 0.250 |
Why?
|
Animals | 44 | 2023 | 168459 | 0.250 |
Why?
|
Mutation | 10 | 2023 | 30052 | 0.240 |
Why?
|
Kallikreins | 3 | 2020 | 220 | 0.240 |
Why?
|
Repressor Proteins | 3 | 2021 | 2986 | 0.240 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2019 | 1606 | 0.230 |
Why?
|
DNA Methylation | 1 | 2018 | 4398 | 0.230 |
Why?
|
Neurofibrosarcoma | 1 | 2023 | 27 | 0.220 |
Why?
|
Mice, Nude | 6 | 2018 | 3615 | 0.220 |
Why?
|
Neoplastic Stem Cells | 2 | 2022 | 1347 | 0.210 |
Why?
|
Pancreatic Neoplasms | 5 | 2017 | 5368 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2023 | 2825 | 0.200 |
Why?
|
TATA Box | 1 | 2021 | 127 | 0.200 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2023 | 170 | 0.200 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2022 | 431 | 0.200 |
Why?
|
Phlebovirus | 1 | 2021 | 2 | 0.200 |
Why?
|
Cytosine Deaminase | 1 | 2021 | 66 | 0.190 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2022 | 76 | 0.190 |
Why?
|
Thymidine | 1 | 2021 | 299 | 0.190 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2021 | 18 | 0.190 |
Why?
|
Mice, Inbred BALB C | 10 | 2020 | 6216 | 0.190 |
Why?
|
Rhabdomyoma | 1 | 2021 | 56 | 0.190 |
Why?
|
Polycystic Kidney Diseases | 1 | 2022 | 133 | 0.190 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3613 | 0.190 |
Why?
|
Microsatellite Instability | 1 | 2024 | 716 | 0.180 |
Why?
|
Cell Movement | 7 | 2021 | 5203 | 0.180 |
Why?
|
Protein Precursors | 2 | 2018 | 1132 | 0.180 |
Why?
|
Intestinal Mucosa | 5 | 2019 | 3032 | 0.180 |
Why?
|
Tongue Neoplasms | 1 | 2022 | 183 | 0.180 |
Why?
|
Tracheoesophageal Fistula | 1 | 2021 | 131 | 0.170 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 305 | 0.170 |
Why?
|
Frontal Lobe | 2 | 2020 | 1420 | 0.170 |
Why?
|
Myelodysplastic Syndromes | 2 | 2022 | 1394 | 0.160 |
Why?
|
Palliative Care | 1 | 2014 | 3598 | 0.160 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2021 | 455 | 0.160 |
Why?
|
Humans | 61 | 2024 | 761504 | 0.160 |
Why?
|
Glioma, Subependymal | 1 | 2017 | 3 | 0.150 |
Why?
|
Killer Cells, Natural | 2 | 2023 | 2200 | 0.150 |
Why?
|
Neurilemmoma | 1 | 2023 | 526 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2803 | 0.150 |
Why?
|
Signal Transduction | 7 | 2021 | 23445 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2021 | 362 | 0.150 |
Why?
|
HEK293 Cells | 3 | 2022 | 4278 | 0.150 |
Why?
|
Neovascularization, Pathologic | 3 | 2020 | 2645 | 0.140 |
Why?
|
Gene Silencing | 3 | 2019 | 1509 | 0.140 |
Why?
|
Keratins | 2 | 2015 | 498 | 0.140 |
Why?
|
Trypsin Inhibitor, Kunitz Soybean | 2 | 2023 | 11 | 0.140 |
Why?
|
Hydrocephalus | 1 | 2022 | 764 | 0.130 |
Why?
|
Neoplasm Transplantation | 2 | 2018 | 2016 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2020 | 823 | 0.130 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2416 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2057 | 0.120 |
Why?
|
Desmosomes | 1 | 2015 | 72 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8547 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1229 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1522 | 0.120 |
Why?
|
Hematopoiesis | 2 | 2022 | 2049 | 0.120 |
Why?
|
Microvessels | 1 | 2019 | 577 | 0.120 |
Why?
|
Disease Progression | 4 | 2021 | 13506 | 0.120 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2016 | 218 | 0.120 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2018 | 651 | 0.120 |
Why?
|
Astrocytoma | 1 | 2019 | 775 | 0.120 |
Why?
|
Ganglioneuroma | 1 | 2014 | 53 | 0.120 |
Why?
|
Male | 30 | 2024 | 360804 | 0.120 |
Why?
|
Sarcoma | 1 | 2005 | 1801 | 0.110 |
Why?
|
Adipocytes, White | 1 | 2014 | 91 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4575 | 0.110 |
Why?
|
Cytodiagnosis | 1 | 2017 | 447 | 0.110 |
Why?
|
Adipocytes, Brown | 1 | 2014 | 150 | 0.110 |
Why?
|
Ghrelin | 1 | 2015 | 252 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1218 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9280 | 0.110 |
Why?
|
Tuberous Sclerosis | 1 | 2021 | 1030 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1248 | 0.110 |
Why?
|
Keratinocytes | 2 | 2015 | 790 | 0.110 |
Why?
|
Gastrins | 1 | 2012 | 74 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2011 | 3602 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 22169 | 0.100 |
Why?
|
Serine Proteases | 1 | 2012 | 50 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1157 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2023 | 1897 | 0.100 |
Why?
|
Histones | 1 | 2022 | 2580 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 791 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 687 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3164 | 0.100 |
Why?
|
Ganglioglioma | 1 | 2011 | 36 | 0.100 |
Why?
|
Mediastinal Neoplasms | 1 | 2014 | 401 | 0.100 |
Why?
|
Prognosis | 5 | 2021 | 29625 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1642 | 0.090 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2011 | 16 | 0.090 |
Why?
|
Trophoblasts | 1 | 2012 | 224 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1745 | 0.090 |
Why?
|
Inflammation | 3 | 2018 | 10773 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2019 | 7856 | 0.090 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6935 | 0.090 |
Why?
|
Immunoblotting | 2 | 2010 | 1646 | 0.090 |
Why?
|
Astrocytes | 1 | 2018 | 1346 | 0.090 |
Why?
|
Mice, Knockout | 9 | 2023 | 14414 | 0.090 |
Why?
|
Phosphorylation | 3 | 2018 | 8320 | 0.090 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4249 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9420 | 0.090 |
Why?
|
Laminin | 2 | 2012 | 408 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11903 | 0.090 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2385 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2015 | 1393 | 0.090 |
Why?
|
Oligodendroglioma | 1 | 2011 | 279 | 0.080 |
Why?
|
Laparoscopy | 1 | 2021 | 2035 | 0.080 |
Why?
|
Hyperplasia | 1 | 2012 | 1152 | 0.080 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2072 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18252 | 0.080 |
Why?
|
Blood Vessels | 1 | 2014 | 1113 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11076 | 0.080 |
Why?
|
Mice, Transgenic | 5 | 2021 | 9539 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4320 | 0.080 |
Why?
|
Ichthyosis | 1 | 2008 | 59 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2449 | 0.080 |
Why?
|
Tissue Kallikreins | 1 | 2008 | 14 | 0.080 |
Why?
|
Apoptosis | 5 | 2021 | 9486 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5671 | 0.070 |
Why?
|
Median Nerve | 1 | 2008 | 132 | 0.070 |
Why?
|
Oligodendroglia | 1 | 2011 | 538 | 0.070 |
Why?
|
Somatomedins | 1 | 2007 | 179 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3455 | 0.070 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2008 | 133 | 0.070 |
Why?
|
Ovalbumin | 1 | 2008 | 677 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2008 | 5789 | 0.070 |
Why?
|
Adult | 13 | 2022 | 221177 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2012 | 1651 | 0.070 |
Why?
|
Sarcoma, Synovial | 1 | 2008 | 153 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13639 | 0.070 |
Why?
|
Arthritis, Experimental | 1 | 2008 | 291 | 0.070 |
Why?
|
Female | 22 | 2022 | 392644 | 0.070 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2007 | 175 | 0.070 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2007 | 189 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13380 | 0.070 |
Why?
|
Parietal Lobe | 1 | 2011 | 852 | 0.070 |
Why?
|
Cell Hypoxia | 1 | 2008 | 656 | 0.070 |
Why?
|
Neoplasms | 5 | 2018 | 22170 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2010 | 0.060 |
Why?
|
Mesoderm | 1 | 2009 | 674 | 0.060 |
Why?
|
Lymphatic Metastasis | 3 | 2021 | 2915 | 0.060 |
Why?
|
Chorioallantoic Membrane | 1 | 2005 | 50 | 0.060 |
Why?
|
Cell Membrane | 2 | 2013 | 3688 | 0.060 |
Why?
|
Placentation | 1 | 2005 | 78 | 0.060 |
Why?
|
Ubiquitination | 2 | 2021 | 1006 | 0.060 |
Why?
|
Hair | 1 | 2008 | 498 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 845 | 0.060 |
Why?
|
Mice, Inbred ICR | 1 | 2005 | 364 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2651 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2917 | 0.060 |
Why?
|
Proteoglycans | 1 | 2007 | 803 | 0.060 |
Why?
|
Mice, SCID | 2 | 2023 | 2626 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2015 | 1896 | 0.060 |
Why?
|
Interferon Type I | 1 | 2007 | 562 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2005 | 778 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2011 | 1695 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2021 | 58976 | 0.050 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2022 | 938 | 0.050 |
Why?
|
Transcription Factors | 2 | 2020 | 12128 | 0.050 |
Why?
|
Dextran Sulfate | 2 | 2015 | 256 | 0.050 |
Why?
|
Cell Cycle | 2 | 2021 | 2932 | 0.050 |
Why?
|
Central Nervous System Neoplasms | 1 | 2011 | 916 | 0.050 |
Why?
|
Intestines | 1 | 2011 | 1909 | 0.050 |
Why?
|
Fibrinolysin | 1 | 2022 | 131 | 0.050 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 3076 | 0.050 |
Why?
|
Plasminogen | 1 | 2022 | 144 | 0.050 |
Why?
|
Middle Aged | 11 | 2022 | 220895 | 0.050 |
Why?
|
Carcinogens | 2 | 2015 | 452 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8708 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2022 | 127 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8465 | 0.050 |
Why?
|
Morphogenesis | 1 | 2005 | 741 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 3 | 2009 | 4511 | 0.050 |
Why?
|
Ticks | 1 | 2021 | 70 | 0.050 |
Why?
|
Tick-Borne Diseases | 1 | 2021 | 36 | 0.050 |
Why?
|
Homozygote | 2 | 2022 | 1776 | 0.050 |
Why?
|
Drug Combinations | 1 | 2007 | 2048 | 0.050 |
Why?
|
Twins, Dizygotic | 1 | 2021 | 236 | 0.050 |
Why?
|
Colony-Forming Units Assay | 1 | 2020 | 352 | 0.040 |
Why?
|
Permeability | 2 | 2013 | 723 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2010 | 6132 | 0.040 |
Why?
|
Aged | 9 | 2021 | 169289 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 320 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2021 | 295 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1612 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2021 | 18965 | 0.040 |
Why?
|
Bone Marrow | 2 | 2021 | 2911 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 421 | 0.040 |
Why?
|
Gene Deletion | 3 | 2013 | 2665 | 0.040 |
Why?
|
Spleen | 1 | 2005 | 2295 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 49 | 0.040 |
Why?
|
Collagen | 1 | 2007 | 2638 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17904 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3778 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 36426 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2005 | 1784 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6485 | 0.040 |
Why?
|
Claudins | 1 | 2019 | 117 | 0.040 |
Why?
|
HeLa Cells | 2 | 2018 | 3093 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 718 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2022 | 1494 | 0.040 |
Why?
|
Whole-Body Irradiation | 1 | 2018 | 433 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1008 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2021 | 2455 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3113 | 0.040 |
Why?
|
Fetal Development | 1 | 2022 | 769 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2010 | 12795 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2018 | 261 | 0.030 |
Why?
|
Japan | 1 | 2021 | 1378 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1667 | 0.030 |
Why?
|
Culture Media, Serum-Free | 1 | 2016 | 148 | 0.030 |
Why?
|
Models, Biological | 3 | 2009 | 9469 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2020 | 727 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2021 | 1834 | 0.030 |
Why?
|
Neurogenesis | 1 | 2022 | 863 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2021 | 3466 | 0.030 |
Why?
|
Azoxymethane | 1 | 2015 | 35 | 0.030 |
Why?
|
Esophagus | 1 | 2021 | 1033 | 0.030 |
Why?
|
Trachea | 1 | 2021 | 1089 | 0.030 |
Why?
|
Regeneration | 1 | 2004 | 1511 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1870 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2022 | 888 | 0.030 |
Why?
|
Protein Stability | 1 | 2017 | 578 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10090 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 522 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2021 | 1271 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2022 | 1265 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2019 | 699 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2016 | 277 | 0.030 |
Why?
|
Tamoxifen | 1 | 2019 | 965 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2005 | 3612 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1533 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1181 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2141 | 0.030 |
Why?
|
Parietal Cells, Gastric | 1 | 2012 | 44 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2416 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 553 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2005 | 4369 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2009 | 3597 | 0.030 |
Why?
|
Organoids | 1 | 2019 | 740 | 0.030 |
Why?
|
Cesarean Section | 1 | 2021 | 1396 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2014 | 957 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 3712 | 0.020 |
Why?
|
Pregnancy | 3 | 2021 | 29874 | 0.020 |
Why?
|
Metaplasia | 1 | 2012 | 322 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2005 | 4580 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27112 | 0.020 |
Why?
|
Azetidines | 1 | 2012 | 142 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26198 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2446 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2735 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5774 | 0.020 |
Why?
|
Time Factors | 3 | 2007 | 39967 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2693 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2011 | 384 | 0.020 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2011 | 350 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4174 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3522 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2014 | 736 | 0.020 |
Why?
|
Up-Regulation | 2 | 2009 | 4124 | 0.020 |
Why?
|
Gastric Mucosa | 1 | 2012 | 604 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2013 | 1827 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2011 | 638 | 0.020 |
Why?
|
Animal Structures | 1 | 2008 | 24 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 662 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3877 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6534 | 0.020 |
Why?
|
Skin | 2 | 2015 | 4484 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2009 | 238 | 0.020 |
Why?
|
Skin Abnormalities | 1 | 2008 | 59 | 0.020 |
Why?
|
Oligopeptides | 1 | 2013 | 1187 | 0.020 |
Why?
|
Cell Line | 2 | 2015 | 15601 | 0.020 |
Why?
|
Serum | 1 | 2009 | 209 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 283 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2008 | 262 | 0.020 |
Why?
|
Injections, Intra-Articular | 1 | 2008 | 280 | 0.020 |
Why?
|
Atrophy | 1 | 2012 | 1633 | 0.020 |
Why?
|
Chimera | 1 | 2008 | 453 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4431 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2010 | 1705 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9318 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5305 | 0.020 |
Why?
|
Organ Specificity | 1 | 2011 | 1967 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9606 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4465 | 0.020 |
Why?
|
Serpins | 1 | 2008 | 247 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10194 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1349 | 0.020 |
Why?
|
Embryo Loss | 1 | 2005 | 55 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 64680 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 931 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2006 | 326 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2004 | 123 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2011 | 1787 | 0.010 |
Why?
|
Cadherins | 1 | 2009 | 903 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 591 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11528 | 0.010 |
Why?
|
Antigens | 1 | 2008 | 1443 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1967 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5671 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 1675 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10000 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5035 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4772 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12974 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2015 | 3802 | 0.010 |
Why?
|
Piperazines | 1 | 2012 | 2523 | 0.010 |
Why?
|
Gene Targeting | 1 | 2005 | 838 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1263 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 1961 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2538 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3429 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3792 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2005 | 1519 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2008 | 1974 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4358 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 2819 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 1897 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80636 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36192 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4174 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9351 | 0.010 |
Why?
|
Antigens, CD | 1 | 2009 | 4003 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59243 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16591 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 3272 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11121 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1626 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5796 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42230 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 4915 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4615 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6346 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4414 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74206 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12441 | 0.010 |
Why?
|
Survival Rate | 1 | 2007 | 12725 | 0.010 |
Why?
|
Child | 1 | 2019 | 80153 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88319 | 0.010 |
Why?
|